---
title: "This Appian Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Thursday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284807953.md"
description: "Top analysts downgraded Appian Corp (APPN) from Overweight to Equal-Weight with a price target cut from $41 to $25, while XOMA Royalty Corp (XOMA) was downgraded from Buy to Neutral with a $39 price target. Appian shares closed at $21.72 and XOMA shares at $40.99 on Wednesday. For more analyst opinions, visit the ratings page."
datetime: "2026-04-30T16:15:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284807953.md)
  - [en](https://longbridge.com/en/news/284807953.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284807953.md)
---

# This Appian Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Morgan Stanley analyst Sanjit Singh downgraded **Appian Corp** (NASDAQ:APPN) from Overweight to Equal-Weight and cut the price target from $41 to $25. Appian shares closed at $21.72 on Wednesday. See how other analysts view this stock.
-   HC Wainwright & Co. analyst Joseph Pantginis downgraded **XOMA Royalty Corp** (NASDAQ:XOMA) from Buy to Neutral and announced a $39 price target. XOMA Royalty shares closed at $40.99 on Wednesday. See how other analysts view this stock.

Considering buying APPN stock? Here’s what analysts think:

_Photo via Shutterstock_

### Related Stocks

- [XOMA.US](https://longbridge.com/en/quote/XOMA.US.md)
- [APPN.US](https://longbridge.com/en/quote/APPN.US.md)
- [XOMAP.US](https://longbridge.com/en/quote/XOMAP.US.md)
- [XOMAO.US](https://longbridge.com/en/quote/XOMAO.US.md)

## Related News & Research

- [District Announces Promising Water Treatment Results from Collaboration with Xoma AB | DMXCF Stock News](https://longbridge.com/en/news/286861678.md)
- [Assessing Whether Appian (APPN) Is Undervalued After Recent Share Price Weakness](https://longbridge.com/en/news/286662827.md)
- [Appian Pitches Reliable AI, $825M Revenue Goal and Bigger Buyback at Investor Day](https://longbridge.com/en/news/286488339.md)
- [Ligand Pharmaceuticals Amends XOMA Royalty Merger Agreement to Add Holding Company](https://longbridge.com/en/news/286776618.md)
- [Appian partners with Snowflake to link AI process orchestration with Snowflake AI Data Cloud](https://longbridge.com/en/news/287020183.md)